It is important to remember that there is more to stroke secondary prevention than antithrombotics. Our use of DAPT in ICAD comes from the SAMMPRIS trial, in which patients in the control group did better than expected compared to historical controls with ICAD in the WASID trial. Recall however, tha...

As we know the mechanism of stroke in ICAD: Artery to artery embolism  Perforator disease  Hypoperfusion  For 1, 2 the best treatment is optimal medical management. While for 3, the treatment can be angioplasty/stenting.If we looked for WASID trial which randomly assigned patients...

I would consider it. If there is an indication for anticoagulation, would continue the anticoagulant and add aspirin only for 30 days if safe.